Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/2011
04/19/2011US7928195 Poly zinc finger proteins with improved linkers
04/19/2011US7928082 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
04/19/2011US7928081 Combined use of PRAME inhibitors and HDAC inhibitors
04/19/2011US7928073 Purified polypeptides having IL-13 receptor activity
04/19/2011US7928071 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
04/19/2011US7928069 Crosslinked compounds and methods of making and using thereof
04/19/2011US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications
04/19/2011US7927873 Polyamides for nucleic acid delivery
04/19/2011US7927870 DNA vaccine formulations
04/19/2011US7927839 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
04/19/2011US7927821 Methods of screening for compounds which bind G protein-coupled receptors
04/19/2011US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
04/19/2011US7927803 Human MutY
04/19/2011US7927793 Cell lines and host nucleic acid sequences related to infectious disease
04/19/2011US7927785 Methods for in vitro expansion of hematopoietic stem cells
04/19/2011US7927611 Compounds and methods for diagnosis and immunotherapy of tuberculosis
04/19/2011US7927610 Compounds and methods for diagnosis and immunotherapy of tuberculosis
04/19/2011US7927599 Chondrocyte therapeutic delivery system
04/19/2011CA2478081C Multiple and multivalent dna vaccines in ovo
04/19/2011CA2447703C Methods for proliferating terminal differentiated cells and recombinant vectors therefor
04/19/2011CA2421258C Truncated bard1 protein, and its diagnostic and therapeutic uses
04/19/2011CA2370289C Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
04/19/2011CA2226301C Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell
04/19/2011CA2208245C Purification of a triple helix formation with an immobilized oligonucleotide
04/14/2011WO2011043913A2 Novel cationic lipids with short lipid chains for oligonucleotide delivery
04/14/2011WO2011042556A1 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing
04/14/2011WO2011020023A3 Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
04/14/2011WO2010140834A9 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof
04/14/2011US20110088106 Compositions and methods for mediating cell cycle progression
04/14/2011US20110086905 Pseudocomplementary Oligonucleotides for Targeted Gene Therapy
04/14/2011US20110086090 Vectors Containing the Max Gene
04/14/2011US20110086072 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen
04/14/2011US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
04/14/2011US20110086040 Method of treating hemolytic disease
04/14/2011US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon
04/14/2011US20110083987 Methods and compositions for tissue regeneration
04/14/2011CA2776834A1 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing
04/14/2011CA2776748A1 Use of pedf in an encapsulated cell-based delivery system
04/13/2011EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis
04/13/2011EP2308987A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation
04/13/2011EP2308981A1 Streptococcal C5a peptidase vaccine
04/13/2011EP2308515A1 Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors
04/13/2011EP2308502A1 Method to induce neovascular formation and tissue regeneration
04/13/2011EP2308473A1 Pharmaceutical composition containing surface-coated microparticles
04/13/2011EP2307575A1 Unprocessed rolling circle amplification product
04/13/2011EP2307542A1 Method for treating or preventing radiation damage by in vivo gene therapy
04/13/2011EP2306978A2 Compositions for the in vivo delivery of rnai agents
04/13/2011EP2306929A1 Medical devices and methods for delivery of nucleic acids
04/13/2011EP1543020B1 Codon optimized synthetic plasmids
04/13/2011EP1458749B1 Bone polypeptide-1
04/13/2011EP1412485B1 Antigen presenting cells, method for their preparation and their use for cancer vaccines
04/13/2011EP0957941B1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE
04/13/2011CN1910456B Marker for neuromyelitis optica
04/13/2011CN1379820B Lentiviral vectors for preparation of immunotherapeutical compositions
04/13/2011CN102014948A Modulation of adenoviral tropism
04/13/2011CN102010863A miRNA for expressing sex difference of Ascaris suum, corresponding prosoma, antisense oligonucleotide and application thereof
04/13/2011CN102010463A Consensus/ancestral immunogens
04/13/2011CN102008735A Small molecular DNA vaccine and preparation method thereof
04/13/2011CN102008724A Method and reagent for inhibiting hepatocellular carcinoma
04/13/2011CN102008718A Application of SIRT (Silent Mating Type Information Regulation 2 Homolog 1) to prepare medicine used for regulating down the expression of cyclin D1
04/13/2011CN102008503A Hematopoietic cells from human embryonic stem cells
04/13/2011CN102008441A Endoglin antibody coupled liposome as well as preparation method and application thereof
04/13/2011CN101633923B Long non-coding RNA sequence relevant to human melanoma cells and application thereof
04/13/2011CN101606948B Application of small interfering RNA in preparing medicament for treating colon cancer
04/12/2011US7923560 Delivery of immune response modifier compounds
04/12/2011US7923548 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
04/12/2011US7923547 for antisense therapy
04/12/2011US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer
04/12/2011US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3
04/12/2011US7923509 Drug delivery compositions and medical devices containing block copolymer
04/12/2011US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors
04/12/2011US7923250 Transfection with nucleic acid; insertion
04/12/2011US7923243 Expression vector comprising glucose regulated protein 78 (grp78) stress-responsive promoter and endoplasmic reticulum stress elements for use in tissue specific heterologous gene expression for treatment and prevention of cell proliferative and inflammatory disorders
04/12/2011US7923017 Modified Vaccinia Ankara virus variant
04/12/2011US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
04/12/2011US7923007 Brain tissue damage therapies
04/12/2011CA2414241C Polymeric micelle compositions
04/12/2011CA2388363C Dna polymerase lambda and uses thereof
04/12/2011CA2354153C Compounds and methods for modulating activation of nf-.kappa.b
04/12/2011CA2326719C Use of triplex structure dna sequences for transferring nucleotide sequences
04/07/2011WO2011041502A1 Aav vectors expressing sec1o for treating kidney damage
04/07/2011WO2011041093A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
04/07/2011WO2011040887A1 A nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells
04/07/2011WO2011040613A1 Therapeutic agent for tumor
04/07/2011WO2011040597A1 Pharmaceutical composition containing medicament-containing fine particles and method for producing same
04/07/2011WO2011040503A1 Method for recovery of sensitivity to anti-cancer agents in cancer cell that acquires resistance to anti-cancer agents
04/07/2011WO2011040428A1 Anti-tumor agent and method for screening for same
04/07/2011WO2011040220A1 Composition for treatment of pancreatic cancer
04/07/2011WO2011002077A8 TNF-α GENE THERAPY AGENT CONTAINED IN POLYMERIC MICELLE
04/07/2011WO2010131916A3 Sirna conjugate and preparation method thereof
04/07/2011WO2010099301A3 Piggybac transposon variants and methods of use
04/07/2011WO2010043630A3 A delivery system for rna
04/07/2011US20110082482 Materials and Methods for Nerve Repair
04/07/2011US20110082191 Method for treating or preventing radiation damage by in vivo gene therapy
04/07/2011US20110082095 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer
04/07/2011US20110081366 Immunostimulatory nucleic acid molecules
04/07/2011US20110081360 Human G-Protein Chemokine Receptor (CCR5) HDGNR10
04/07/2011US20110081359 Alpha 5 beta 1 and its ability to regulate the cell survival pathway
04/07/2011US20110081332 Treatment of non-alcoholic steatotic hepatitis (nash)
04/07/2011US20110079528 Oligonucleotide compositions and methods for treating disease including inflammatory conditions